甲基马诱导的胆固醇黄:一个罕见的病例和文献综述
Ahmed Mohamed Nefzi1, Dhouha Cherif1, Habiba Dabbebi1
1Gastroenterology B Department, La Rabta Hospital, Tunis, Tunisia.
Journal of investigative medicine high impact case reports
|February 6, 2025
概括
甲基马,用于甲状腺功能障碍症,很少会导致严重的胆固醇黄. 患有黄或等症状的患者应立即停止服用药物.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲基马是一种常见的甲状腺功能障碍的治疗方法.
- 虽然通常是安全的,但已知罕见的不良反应,如农细胞瘤和肝毒性.
- 胆固醇黄是一种严重但不常见的并发症.
研究的目的:
- 报告一种由甲基马诱导的胆固醇黄病例.
- 为了强调认识到这种罕见的不良影响的重要性.
主要方法:
- 一个27岁的女性患有格雷夫斯病的案例介绍.
- 临床观察症状,实验室检查和治疗反应.
- 排除肝病的其他原因.
主要成果:
- 患者在开始服用甲基马后13天出现严重的和胆固醇黄.
- 停用甲基马和启动皮质类固醇和放射性治疗导致症状的消失.
- 肝功能在两年内正常化,最初的胆固醇病变加重,随后逐渐下降.
结论:
- 甲基马可以诱导罕见但严重的胆固醇黄.
- 早期识别和停止使用甲基马对于患者的管理至关重要.
- 患者应接受有关和黄等潜在症状的教育.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Diseases of the Liver and Gallbladder
418
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
418
Chronic Pancreatitis II: Collaborative Care
60
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
60


